Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure.
Despite having amenorrhea and markedly elevated serum gonadotropin levels, some women with karyotypically normal spontaneous premature ovarian failure, nevertheless, have ovarian follicles that function intermittently. Graafian follicles capable of responding to these high FSH levels are faced with high serum LH levels as well, which might induce inappropriate luteinization and prevent normal follicle function. We examined this possibility using weekly blood sampling and sonography in 65 patients. Nearly 50% of our patients demonstrated ovarian follicle function [serum estradiol, > 183 pmol/L (50 pg/mL)] during a median of 4 months of observation (range, 2-6 months). However, during this observation, only 16% achieved an ovulatory serum progesterone level [> 9.5 nmol/L (3.0 ng/mL)]. We imaged an antral follicle by sonography in over 40% of patients (27 of 65), and serum estradiol was significantly greater when an antral follicle was present. The follicles in these patients were not functioning normally, however. In contrast to normal women, patients with ovarian failure had poor correlation between follicle diameter and serum estradiol. We biopsied these antral follicles in 6 patients and found luteinized Graafian follicles in all cases. Therefore, luteinized Graafian follicles account for at least 60% of the antral structures imaged (95% confidence limit). Thus, inappropriate luteinization of Graafian follicles appears to be a major pathophysiological mechanism in patients with karyotypically normal spontaneous premature ovarian failure.
Section on Gynecologic Research, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
L M
LM
Nelson
J N
JN
Anasti
L M
LM
Kimzey
R A
RA
Defensor
K J
KJ
Lipetz
B J
BJ
White
T H
TH
Shawker
M J
MJ
Merino
D000328:Adult; D001706:Biopsy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007621:Karyotyping; D008183:Luteal Phase / Q000502:physiology; D007986:Luteinizing Hormone / Q000032:analysis* / Q000097:blood / Q000502:physiology; D006080:Ovarian Follicle / Q000737:chemistry* / Q000473:pathology*; D010053:Ovary / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D016649:Primary Ovarian Insufficiency / Q000097:blood / Q000000981:diagnostic imaging / Q000473:pathology*; D011863:Radioimmunoassay; D014463:Ultrasonography
D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone